Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News SCCT 2025

Adding Coronary CT Angiography to Annual Firefighter Physicals Could Save Lives

Yael L. Maxwell

July 18, 2025

News Daily News

CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake

Yael L. Maxwell

June 25, 2025

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Daily News

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

Caitlin E. Cox

March 28, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men

Michael O'Riordan

January 10, 2023

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Conference News ACC 2017

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

Yael L. Maxwell

March 18, 2017

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

News Daily News

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

L.A. McKeown

January 12, 2012

Advertisement

Adding Coronary CT Angiography to Annual Firefighter Physicals Could Save Lives

CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content